| |
| Device | OCS Heart System |
| Generic Name | Organ care system (OCS) heart system |
| Applicant | TransMedics, Inc. 200 Minuteman Rd., Suite 302 Andover, MA 01810 |
| PMA Number | P180051 |
| Supplement Number | S001 |
| Date Received | 11/08/2021 |
| Decision Date | 04/27/2022 |
| Product Code |
QIK |
| Docket Number | 22M-0715 |
| Notice Date | 05/03/2022 |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT03831048
|
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the Organ Care System (OCS) Heart System for expanding the indication to include donation-after-circulatory-death (DCD) donor hearts. The device is indicated for the preservation of donation-after-brain-death (DBD) hearts initially deemed unsuitable for procurement and transplantation at initial evaluation due to limitations of prolonged cold static cardioplegic preservation (e.g., > 4 hours of cross-clamp time). The OCS Heart System is also indicated for the ex vivo reanimation, functional monitoring, and beating-heart preservation of DCD hearts. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Post-Approval Study | Show Report Schedule and Study Progress |